SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

ACADIA Pharmaceuticals Price Target Cut to $33.00/Share From $40.00 by Citigroup

Ratings actions from Benzinga: GMT) ACADIA Pharmaceuticals Is Maintained at Buy by CitigroupRatings actions from Benzinga

ACAD

Related stories